Pharmacological interventions for adolescents and adults with ADHD: Stimulant and nonstimulant medications and misuse of prescription stimulants

Psychology Research and Behavior Management

Volumn 7, Issue , 2014, Pages 223-249

  Weyandt, Lisa L ^a   Oster, Danielle R ^a   Marraccini, Marisa E ^a   Gudmundsdottir, Bergljot Gyda ^a   Munro, Bailey A ^a   Zavras, Brynheld Martinez ^a   Kuhar, Ben ^a  

^a UNIVERSITY OF RHODE ISLAND   (United States)

Author keywords

ADHD symptomatology; Amphetamine; Lisdexamfetamine; Methylphenidate; Nonmedical stimulant use; Pharmacotherapy

Indexed keywords

EID: 84907284463     PISSN: None     EISSN: 11791578     Source Type: Journal    
DOI: 10.2147/PRBM.S47013     Document Type: Review

References (131)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Health Disorders:DSM-5. 5th ed. Washington, DC:American Psychiatric Publishing;2013.
2. Barkley RA, Murphy KR, Fischer, M. ADHD in Adults:What the Science Says. New York, NY:Guilford;2008.
3. Resnick RJ. Attention deficit hyperactivity disorder in teens and adults:they don’t all outgrow it. J Clin Psychol. 2005;61(5):529–533.
4. Kessler RC, Adler L, Barkley R, et al. The prevalence and correlates of adult ADHD in the United States:results from the National Comorbidity Survey replication. Am J Psychiatry. 2006;163(4):716–723.
5. Faraone SV, Biederman J, Lehman BK, et al. Intellectual performance and school failure in children with attention deficit hyperactivity disorder and in their siblings. J Abnorm Child Psychol. 1993;102(4):616–623.
6. Barkley RA. Attention-Deficit Hyperactivity Disorder:A Handbook for Diagnosis and Treatment. 3rd ed. New York:Guilford;2006.
7. Danforth JS, Connor DF, Doerfler LA. The development of comorbid conduct problems in children with ADHD:an example of an integrative developmental psychopathology perspective. J Atten Disord. Epub January 10, 2014.
8. Barkley RA, Fischer M, Edelbrock CS, Smallish L. The adolescent outcome of hyperactive children diagnosed by research criteria:an 8-year prospective follow-up study. J Am Acad Child Adolesc Psychiatry. 1990;29(4):546–557.
9. Molina BS, Hinshaw SP, Swanson JM, et al;for the MTA Cooperative Group. The MTA at 8 years:prospective follow-up of children treated for combined-type ADHD in a multisite study. J Am Acad Child Adolesc Psychiatry. 2009;48(5):484–500.
10. Biederman J, Mick E, Faraone SV. Age-dependent decline of symptoms of attention deficit hyperactivity disorder:impact of remission definition and symptom type. Am J Psychiatry. 2000;157(5):816–818.
11. Weyandt LL, Iwaszuk W, Fulton K, et al. The Internal Restlessness Scale:performance of college students with and without ADHD. J Learn Disabil. 2003;36(4):382–389.
12. Sibley MH, Kuriyan AB, Evans SW, Waxmonsky JG, Smith BH. Pharmacological and psychosocial treatments for adolescents with ADHD:an updated systematic review of the literature. Clin Psychol Rev. 2014;34(3):218–232.
13. Weyandt LL, DuPaul GJ. College Students with ADHD:Current Status and Future Directions. New York:Springer;2013.
14. Americans With Disabilities Act 1991, Pub L No 101–336, 26 July 1990, 104 Stat 328 (1991). Available from http://www.ada.gov/pubs/adastatute08.htm. Accessed July 25, 2014.
15. Wolf LE, Simkowitz P, Carlson H. College students with attention-deficit/hyperactivity disorder. Curr Psychiatry Rep. 2009;11(5):415–421.
16. Weyandt LL, Linterman I, Rice JA. Reported prevalence of attention difficulties in a general sample of college students. J Psychopathol Behav Assess. 1995;17(3):293–304.
17. Garnier-Dykstra LM, Pinchevsky GM, Caldeira KM, Vincent KB, Arria AM. Self-reported adult attention-deficit/hyperactivity disorder symptoms among college students. J Amer Coll Health Assoc. 2010;59(2):133–136.
18. Heiligenstein E, Conyers LM, Berns AR, Miller MA. Preliminary normative data on DSM-IV attention deficit hyperactivity disorder in college students. J Amer Coll Health Assoc. 1998;46(4):185–188.
19. McKee T. Comparison of a norm-based versus criterion-based approach to measuring ADHD symptomatology in college students. J Attent Disord. 2008;11(6):677–688.
20. Norwalk K, Norvilitis JM, MacLean MG. ADHD symptomatology and its relationship to factors associated with college adjustment. J Attent Disord. 2009;13(3):251–258.
21. Shaw-Zirt B, Popali-Lehane L, Chaplin W, Bergman A. Adjustment, social skills, and self-esteem in college students with symptoms of ADHD. J Attent Disord. 2005;8(3):109–120.
22. Advokat C., Lane SM, Luo C. College students with and without ADHD:comparison of self-report of medication usage, study habits, and academic achievement. J Attent Disord. 2011;15(8):656–666.
23. Heiligenstein E, Guenther G, Levy A, Savino F, Fulwiler J. Psychological and academic functioning in college students with attention deficit hyperactivity disorder. Coll Health. 1999;47(4):181–185.
24. Reaser A, Prevatt F, Petscher Y, Proctor B. The learning and study strategies of college students with ADHD. Psychol Sch. 2007;44(6):627–638.
25. Weyandt LL, Rice JA, Linterman I, Mitzlaff L, Emert E. Neuropsychological performance of a sample of adults with ADHD, developmental reading disorder, and controls. Dev Neuropsychol. 1998;14(4):643–656.
26. Canu WH, Carlson CL. Rejection sensitivity and social outcomes of young adult men with ADHD. J Atten Disord. 2007;10(3):261–275.
27. Rabiner DL, Anastopoulos AD, Costello EJ, Hoyle RH, McCabe SE, Swartzwelder HS. Adjustment to college in students with ADHD. J Atten Disord. 2008;11(6):689–699.
28. Baverstock AC, Finlay F. Who manages the care of students with attention deficit hyperactivity disorder (ADHD) in higher education? Child Care Health Dev. 2003;29(3):163–166.
29. Spencer TJ, Biederman J, Wilens T. Pharmacotherapy of ADHD with antidepressants. In:Barkley R, editors. Attention-Deficit Hyperactivity Disorder:A Handbook for Diagnosis and Treatment. 2nd ed. New York:Guilford Press;1998:552–563.
30. Bushe CJ, Savill NC. Systematic review of atomoxetine data in childhood and adolescent attention-deficit hyperactivity disorder 2009–2011:focus on clinical efficacy and safety. J Psychopharmacol. (Oxford, England). 2014;28(3):204–211.
31. Faraone SV, Biederman J, Spencer T, et al. Efficacy of atomoxetine in adult attention-deficit/hyperactivity disorder:a drug-placebo response curve analysis. Behav Brain Funct. 2005;1:16.
32. Kooij SJ, Bejerot S, Blackwell A, et al. European consensus statement on diagnosis and treatment of adult ADHD:the European Network Adult ADHD. BMC Psychiatry. 2010;10:67.
33. Ni HC, Shang CY, Gau SS, Lin YJ, Huang HC, Yang LK. A head-to-head randomized clinical trial of methylphenidate and atomoxetine treatment for executive function in adults with attention-deficit hyperactivity disorder. Int J Neuropsychopharmacol. 2013;16(9):1959–1973.
34. Adler LA, Spencer T, McGough JJ, Jiang H, Muniz R. Long-term effectiveness and safety of dexmethylphenidate extended release capsules in adult ADHD. J Atten Disord. 2009;12(5):449–459.
35. Adler LA, Dirks B, Deas PF, et al. Lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder who report clinically significant impairment in executive function:results from a randomized, double-blind, placebo-controlled study. J Clin Psychiatry. 2013;74(7):694–702.
36. Advokat C. What are the cognitive effects of stimulant medications? Emphasis on adults with attention-deficit/hyperactivity disorder (ADHD). Neurosci Biobehav Rev. 2010;34(8):1256–1266.
37. DuPaul GJ, Weyandt LL, Rossi, JS, et al. Double-blind, placebo-controlled, crossover study of the efficacy and safety of lisdexamfetamine dimesylate in college students with ADHD. J Atten Disord. 2012;16(3):202–220.
38. DuPaul GJ, Weyandt LL, O’Dell, SM, Varejao M. College students with ADHD:current status and future directions. J Atten Disord. 2009;13(3):234–250.
39. Heiligenstein E, Guenther G, Hsu K, Herman K. Depression and academic impairment in college students. J Amer Coll Health Assoc. 1996;45(2):59–64.
40. Huss M, Ginsberg Y, Tvedten T, et al. Methylphenidate hydrochloride modified release improved inattention and hyperactivity/impulsivity scores in adult ADHD patients. Eur Neuropsychopharmacol. 2013;23(2):604–605.
41. Staufer WB, Greydanus DE. Attention-deficit/hyperactivity disorder psychopharmacology for college students. Pediatr Clin North Amer. 2005;52(1):71–84.
42. Weyandt LL, DuPaul GJ. ADHD in college students:a review of the literature. J Atten Disord. 2006;10(1):9–19.
43. Kollins SH. Abuse liability of medications used to treat attention-deficit/hyperactivity disorder (ADHD). Amer J Addict. 2007;16(1):35–44.
44. Weyandt LL, Janusis G, Wilson KG, et al. Nonmedical prescription stimulant use among a sample of college students:relationship with psychological variables. J Atten Disord. 2009;13(3):284–296.
45. Weyandt LL, Marraccini ME, Gudmundsdottir BG, et al. Misuse of prescription stimulants among college students:a review of the literature and implications for morphological and cognitive effects on brain functioning. Exp Clin Psychopharmacol. 2013;21(5):385–407.
46. Babcock Q, Byrne T. Student perceptions of methylphenidate abuse at a public liberal arts college. J Amer Coll Health Assoc. 2009;49(3):143–145.
47. Dussault C, Weyandt LL. An examination of prescription stimulant misuse and psychological variables among sorority and fraternity college populations. J Atten Disord. 2013;17(2):87–97.
48. Judson R, Langdon SW. Illicit use of prescription stimulants among college students:prescription status, motives, theory of planned behaviour, knowledge and self-diagnostic tendencies. Health Psychol Behav Med. 2009;14(1):97–104.
49. Rabiner DL, Anastopoulos AD, Costello EJ, Hoyle RH, McCabe SE, Swartzwelder HS. Motives and perceived consequences of nonmedical ADHD medication use by college students:are students treating themselves for attention problems? J Atten Disord. 2009;13(3):259–270.
50. Verdi G, Weyandt LL, Zavras BM. Non-medical prescription stimulant use in graduate students:relationship with academic self-efficacy and psychological variables. J Atten Disord. Epub April 22, 2014.
51. McCabe SE, Knight JR, Teter CJ, Wechsler H. Non-medical use of prescription stimulants among US college students:prevalence and correlates from a national survey. Br J Addict. 2005;99(1):96–106.
52. Sharp JT, Rosén, LA. Recreational stimulant use among college students. J Subst Use. 2007;12(2):71–82.
53. Dupont RL, Coleman JJ, Bucher RH, Wilford BB. Characteristics and motives of college students who engage in nonmedical use of methylphenidate. Am J Addict. 2008;17(3):167–171.
54. DeSantis AD, Webb EM, Noar SM. Illicit use of prescription ADHD medications on a college campus:a multimethodological approach. J Am Coll Health Assoc. 2008;57(3):315–324.
55. US Food and Drug Administration. FDA Directs ADHD Drug Manufacturers to Notify Patients About Cardiovascular Adverse Events and Psychiatric Adverse Events;2007. Available from:http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2007/ucm108849.htm. Accessed June 25, 2014.
56. Garnier-Dykstra LM, Caldeira KM, Vincent KB, O’Grady KE, Arria AM. Nonmedical use of prescription stimulants during college:four-year trends in exposure opportunity, use, motives, and sources. J Am Coll Health Assoc. 2012;60(3):226–234.
57. Arria AM, Garnier-Dykstra LM, Caldeira KM, Vincent KB, O’Grady KE, Wish ED. Persistent nonmedical use of prescription stimulants among college students:possible association with ADHD symptoms. J Atten Disord. 2011;15(5):347–356.
58. Teter CJ, Falone AE, Cranford JA, Boyd CJ, McCabe SE. Non-medical use of prescription stimulants and depressed mood among college students:frequency and routes of administration. J Subst Abuse Treat. 2010;38(3):292–298.
59. Okoli C, Schabram K. A guide to conducting a systematic literature review of information systems research. Sprouts:Working Papers on Information Systems. 2010;10(26):1–49.
60. Cohen J. A power primer. Psychol Bull. 1992;112:155–159.
61. Adler LA, Goodman D., Kollins SH, et al. Double-blind, placebo-controlled study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder. J Clin Psychiatry. 2008;69(9):1364–1373.
62. Faraone SV, Spencer TJ, Kollins SH, Glatt SJ, Goodman D. Dose response effects of lisdexamfetamine dimesylate treatment in adults with ADHD:an exploratory study. J Atten Disord. 2012;16(2):118–127.
63. Kollins SH, Youcha S, Lasser R, Thase ME. Lisdexamfetamine dimesylate for the treatment of attention deficit hyperactivity disorder in adults with a history of depression or history of substance use disorder. Innov Clin Neurosci. 2011;8(2):28–32.
64. Wigal SB, Wigal T, Schuck S, et al. Academic, behavioral, and cognitive effects of OROS methylphenidate on older children with attention deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol. 2011;21(2):121–131.
65. Findling RL, Childress AC, Cutler AJ, et al. Efficacy and safety of lisdexamfetamine dimesylate in adolescents with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2011;50(4):395–405.
66. Brams M, Giblin J, Gasior M, Gao J, Wigal T. Effects of open-label lisdexamfetamine dimesylate on self-reported quality of life in adults with ADHD. Postgrad Med. 2011;123(3):99–108.
67. Brams M, Weisler R, Findling RL, et al. Maintenance of efficacy of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder:randomized withdrawal design. J Clin Psychiatry. 2012;73(7):977–983.
68. Agay N, Yechiam E, Carmel Z, Levkovitz Y. Non-specific effects of methylphenidate (Ritalin) on cognitive ability and decision-making of ADHD and healthy adults. Psychopharmacology (Berl). 2010;210(4):511–519.
69. Jain U, Hechtman L, Weiss M, et al. Efficacy of a novel biphasic controlled-release methylphenidate formula in adults with attention-deficit/hyperactivity disorder:results of a double-blind, placebo-controlled crossover study. J Clin Psychiatry. 2007;68(2):268–277.
70. Medori R, Ramos-Quiroga JA, Casas M, et al. A randomized, placebo-controlled trial of three fixed dosages of prolonged-release OROS methylphenidate in adults with attention-deficit/hyperactivity disorder. Biol Psychiatry. 2008;63(10):981–989.
71. Retz W, Rösler M, Ose C, et al. Multiscale assessment of treatment efficacy in adults with ADHD:a randomized placebo-controlled, multi-centre study with extended-release methylphenidate. World J Biol Psychiatry. 2012;13(1):48–59.
72. Spencer T, Biederman J, Wilens T, et al. A large, double-blind, randomized clinical trial of methylphenidate in the treatment of adults with attention-deficit/hyperactivity disorder. Biol Psychiatry. 2005;57(5):456–463.
73. Spencer T, Wilens T, Biederman J, Weisler R, Read S, Pratt R. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients:a 4-week, randomized, double-blind, placebo-controlled, parallel-group study. Clin Ther. 2006;28(2):266–279.
74. Spencer TJ, Adler LA, McGough JJ, Muniz R, Jiang H, Pestreich L. Efficacy and safety of dexmethylphenidate extended-release capsules in adults with attention-deficit/hyperactivity disorder. Biol Psychiatry. 2007;61(12):1380–1387.
75. Stein MA, Waldman ID, Charney E, et al. Dose effects and comparative effectiveness of extended release dexmethylphenidate and mixed amphetamine salts. J Child and Adolesc Psychopharmacol. 2011;21(6):581–588.
76. Rösler M, Fischer R, Ammer R, Ose C, Retz W. A randomized, placebo-controlled, 24-week, study of low-dose extended-release methylphenidate in adults with attention deficit/hyperactivity disorder. Eur Arch Psychiatry Clin Neurosci. 2009;259(2):120–129.
77. Rösler M, Retz W, Fischer R, et al. Twenty-four-week treatment with extended release methylphenidate improves emotional symptoms in adult ADHD. World J Biol Psychiatry. 2010;11(5):709–718.
78. Mikami AY, Cox DJ, Davis MT, Wilson HK, Merkel RL, Burket R. Sex differences in effectiveness of extended-release stimulant medication among adolescents with attention-deficit/hyperactivity disorder. J Clin Psychol Med Settings. 2009;16(3):233–242.
79. Bouffard R, Hechtman L, Minde K, Iaboni-Kassab F. The efficacy of 2 different dosages of methylphenidate in treating adults with attention-deficit hyperactivity disorder. Can J Psychiatry. 2003;48(8):546–554.
80. Kooij JJ, Burger H, Boonstra AM, Van der Linden PD, Kalma LE, Buitelaar JK. Efficacy and safety of methylphenidate in 45 adults with attention-deficit/hyperactivity disorder:a randomized placebo-controlled double-blind cross-over trial. Psychol Med. 2004;34(6):973–982.
81. Spencer TJ, Adler LA, Weisler RH, Youcha, SH. Triple-bead mixed amphetamine salts (SPD465), a novel, enhanced extended-release amphetamine formulation for the treatment of adults with ADHD:a randomized, double-blind, multicenter, placebo-controlled study. J Clin Psychiatry. 2008;69(9):1437–1448.
82. Weisler RH, Biederman J, Spencer TJ, et al. Mixed amphetamine salts extended-release in the treatment of adult ADHD:a randomized, controlled trial. CNS Spectr. 2006;11(8):625–639.
83. Biederman J, Mick E, Spencer T, et al. An open-label trial of OROS methylphenidate in adults with late-onset ADHD. CNS Spectr. 2006;11(5):390–396.
84. Wilens T, Kratochvil C, Newcorn J, Gao H. Do children and adolescents with ADHD respond differently to atomoxetine? J Am Acad Child and Adolesc Psychiatry. 2006;45(2):149–157.
85. Wilson HK, Cox DJ, Merkel RL, Moore M, Coghill D. Effect of extended release stimulant-based medications on neuropsychological functioning among adolescents with attention-deficit/hyperactivity disorder. Arch Clin Neuropsychol. 2006;21:797–807.
86. Cooper WO, Habel LA, Sox CM, et al. ADHD drugs and serious cardiovascular events in children and young adults. N Engl J Med. 2011;365(20):1896–1904.
87. Novak SP, Kroutil LA, Williams RL, Van Brunt DL. The nonmedical use of prescription ADHD medications:results from a national Internet panel. Subst Abuse Treat Prev Policy. 2007;2:32.
88. Pilkinton M, Cannatella A. Nonmedical use of prescription stimulants:age, race, gender, and educational attainment patterns. J Hum Behav Soc Environ. 2012;22(4):409–420.
89. Darredeau C, Barrett SP, Jardin B, Pihl RO. Patterns and predictors of medication compliance, diversion, and misuse in adult prescribed methylphenidate users. Hum Psychopharmacol. 2007;22(8):529–536.
90. DeSantis A, Noar SM, Webb EM. Nonmedical ADHD stimulant use in fraternities. J Stud Alcohol Drugs. 2009;70(6):952–954.
91. Herman-Stahl MA, Krebs CP, Kroutil LA, Heller DC. Risk and protective factors for nonmedical use of prescription stimulants and methamphetamine among adolescents. J Adolesc Health. 2006;39(3):374–380.
92. McCabe S, Teter CJ, Boyd CJ. The use, misuse and diversion of prescription stimulants among middle and high school students. Subst Use Misuse. 2004;39(7):1095–1116.
93. Sweeney CT, Sembower MA, Ertischek MD, Shiffman S, Schnoll SH. Nonmedical use of prescription ADHD stimulants and preexisting patterns of drug abuse. J Addict Dis. 2013;32(1):1–10.
94. Veliz P, Boyd C, McCabe SE. Adolescent athletic participation and nonmedical Adderall use:an exploratory analysis of a performance-enhancing drug. J Stud Alcohol Drugs. 2013;74(5):714–719.
95. Gordon S, Tulak F, Troncale J. Prevalence and characteristics of adolescent patients with co-occurring ADHD and substance dependence. J Addict Dis. 2004;23(4):31–40.
96. Williams RJ, Goodale LA, Shay-Fiddler MA, Gloster SP, Chang SY. Methylphenidate and dextroamphetamine abuse in substance-abusing adolescents. Am J Addict. 2004;13(4):381–389.
97. Bright GM. Abuse of medications employed for the treatment of ADHD:results from a large-scale community survey. Medscape J Med. 2008;10:111.
98. McCabe SE, West B. Medical and nonmedical use of prescription stimulants:results from a national multicohort study. J Am Acad Child Adolesc Psychiatry. 2013;52(12):1272–1280.
99. Franke AG, Bonertz, CC, Christmann MM, et al. Non-medical use of prescription stimulants and illicit use of stimulants for cognitive enhancement in pupils and students in Germany. Pharmacopsychiatry, 2011;44(2):60–66.
100. Jeffers A, Benotsch EG, Koester S. Misuse of prescription stimulants for weight loss, psychosocial variables, and eating disordered behaviors. Appetite. 2013;65:8–13.
101. McCabe SE, Teter CJ, Boyd CJ. Medical use, illicit use and diversion of prescription stimulant medication. J Psychoactive Drugs. 2006;38(1):43–56.
102. McCabe SE, Teter CJ. Drug use related problems among nonmedical users of prescription stimulants:a web-based survey of college students from a Midwestern university. Drug Alcohol Depend. 2007;91(1):69–76.
103. Advokat C., Guidry D, Martino L. Licit and illicit use of medications for attention-deficit hyperactivity disorder in undergraduate college students. J Am Coll Health Assoc. 2008;56(6):601–606.
104. Jardin B, Looby A, Earleywine M. Characteristics of college students with attention-deficit hyperactivity disorder symptoms who misuse their medications. J Am Coll Health Assoc. 2011;59(5):373–377.
105. Habibzadeh A, Alizadeh M, Malek A, Maghbooli L, Shoja MM, Ghabil K. Illicit methylphenidate use among Iranian medical students:prevalence and knowledge. Drug Des Devel Ther. 2011;5:71–76.
106. Tuttle JP, Scheurich NE, Ranseen J. Prevalence of ADHD diagnosis and nonmedical prescription stimulant use in medical students. Acad Psychiatry. 2010;34(3):220–223.
107. Emanuel RM, Frellsen SL, Kashima KJ, Sanguino SM, Sierles FS, Lazarus CJ. Cognitive enhancement drug use among future physicians:findings from a multi-institutional census of medical students. J Gen Intern Med. 2013;28(8):1028–1034.
108. Bossaer JB, Gray JA, Miller SE, Enck G, Gaddipati VC, Enck RE. The use and misuse of prescription stimulants as “cognitive enhancers”by students at one academic health sciences center. Acad Med. 2013;88(7):967–971.
109. McNiel AD, Muzzin KB, DeWald JP, et al. The nonmedical use of prescription stimulants among dental and dental hygiene students. J Dent Educ. 2011;75:365–376.
110. White BP, Becker-Blease KA, Grace-Bishop K. Stimulant medication use, misuse, and abuse in an undergraduate and graduate student sample. J Am Coll Health Assoc. 2006;54(5):261–268.
111. Lensing MB, Zeiner P, Sandvik L, Opjordsmoen S. Adults with ADHD:use and misuse of stimulant medication as reported by patients and their primary care physicians. Atten Defic Hyperact Disord. 2013;5(4):369–376.
112. McCabe SE, Teter CJ, Boyd CJ. Medical use, illicit use, and diversion of abusable prescription drugs. J Am Coll Health Assoc. 2006;54(5):269–278.
113. Teter CJ, McCabe S, Cranford JA, Boyd CJ, Guthrie SK. Prevalence and motives for illicit use of prescription stimulants in an undergraduate student sample. J Am Coll Health Assoc. 2005;53(6):253–262.
114. Herman-Stahl M, Krebs CP, Kroutil LA, Heller DC. Risk and protective factors for methamphetamine use and nonmedical use of prescription stimulants among young adults aged 18 to 25. Addict Behav. 2007;32(5):1003–1015.
115. Moore D, Burgard D, Larson R, Ferm M. Psychostimulant use among college students during periods of high and low stress:an interdisciplinary approach utilizing both self-report and unobtrusive chemical sample data. Addict Behav. 2014;39(5):987–993.
116. Lookatch SJ, Dunne EM, Katz EC. Predictors of nonmedical use of prescription stimulants. J Psychoactive Drugs. 2012;44(1):86–91.
117. Janusis GM, Weyandt LL. An exploratory study of substance use and misuse among college students with and without ADHD and other disabilities. J Attent Disord. 2010;14(3):205–215.
118. Barrett S, Darredeau C, Bordy LE, Pihl RO. Characteristics of methylphenidate misuse in a university student sample. Can J Psychiatry. 2005;50(8):457–461.
119. Sepulveda DR, Thomas LM, McCabe SE, Cranford JA, Boyd CJ, Teter CJ. Misuse of prescribed stimulant medication for ADHD and associated patterns of substance use:preliminary analysis among college students. J Pharm Pract. 2011;24(6):551–560.
120. Westover AN, Halm EA. Do prescription stimulants increase the risk of adverse cardiovascular events? A systematic review. BMC Cardiovasc Disord. 2012;12:41.
121. Arria AM, O’Grady KE, Caldeira KM, Vincent KB, Wish ED. Nonmedical use of prescription stimulants and analgesics:associations with social and academic behaviors among college students. J Drug Issues. 2008;38(4):1045–1060.
122. Ilieva I, Boland J, Farah MJ. Objective and subjective cognitive enhancing effects of mixed amphetamine salts in healthy people. Neuropharmacology. 2013;64:496–505.
123. Svetlov SI, Kobeissy FH, Gold MH. Performance enhancing, non-prescription use of Ritalin:a comparison with amphetamines and cocaine. J Addict Dis. 2007;26(4):1–6.
124. Teter CJ, McCabe SE, LaGrange K, Cranford JA, Boyd CJ. Illicit use of specific prescription stimulants among college students:prevalence, motives, and routes of administration. Pharmacotherapy. 2006;26(10):1501–1510.
125. Lord S, Downs G, Furtaw P, et al. Nonmedical use of prescription opioids and stimulants among student pharmacists. J Am Pharm Assoc. 2009;49(4):519–528.
126. Mansbach RS, Moore RA. Formulation considerations for the development of medications with abuse potential. Drug Alcohol Depend. 2006;83(1):15–22.
127. Jasinski DR, Krishnan S. Abuse liability and safety of oral lisdexamfetamine dimesylate in individuals with a history of stimulant abuse. J Psychopharmacol. 2009;23:419–427.
128. Hartung CM, Canu WH, Cleveland CS, et al. Stimulant medication use in college students:comparison of appropriate users, misusers, and nonusers. Psychol Addict Behav. 2013;27(3):832–840.
129. Kroutil LA, Van Brunt DL, Herman-Stahl MA, Heller DC, Bray BM, Penne MA. Nonmedical use of prescription stimulants in the United States. Drug Alcohol Depend. 2006;84:135–143.
130. Clegg-Kraynok MM, McBean MM, Montgomery-Downs HE. Sleep quality and characteristics of college students who use prescription psychostimulants nonmedically. Sleep Med. 2011;12:598–602.
131. Winhusen TM, Lewis DF, Riggs PD, et al. Subjective effects, misuse, and adverse effects of osmotic-release methylphenidate treatment in adolescent substance abusers with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol. 2011;21:455–463.